Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.20
STJ's Cash to Debt is ranked lower than
89% of the 318 Companies
in the Global Medical Devices industry.

( Industry Median: 2.38 vs. STJ: 0.20 )
Ranked among companies with meaningful Cash to Debt only.
STJ' s 10-Year Cash to Debt Range
Min: 0.01  Med: 0.34 Max: No Debt
Current: 0.2
Equity to Asset 0.41
STJ's Equity to Asset is ranked lower than
80% of the 280 Companies
in the Global Medical Devices industry.

( Industry Median: 0.66 vs. STJ: 0.41 )
Ranked among companies with meaningful Equity to Asset only.
STJ' s 10-Year Equity to Asset Range
Min: 0.38  Med: 0.57 Max: 0.83
Current: 0.41
0.38
0.83
Interest Coverage 13.54
STJ's Interest Coverage is ranked lower than
80% of the 167 Companies
in the Global Medical Devices industry.

( Industry Median: 10000.00 vs. STJ: 13.54 )
Ranked among companies with meaningful Interest Coverage only.
STJ' s 10-Year Interest Coverage Range
Min: 7.08  Med: 17.45 Max: 9999.99
Current: 13.54
7.08
9999.99
F-Score: 6
Z-Score: 3.90
M-Score: -2.67
WACC vs ROIC
2.24%
15.79%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 20.77
STJ's Operating margin (%) is ranked higher than
90% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. STJ: 20.77 )
Ranked among companies with meaningful Operating margin (%) only.
STJ' s 10-Year Operating margin (%) Range
Min: 13.95  Med: 19.97 Max: 24.73
Current: 20.77
13.95
24.73
Net-margin (%) 18.11
STJ's Net-margin (%) is ranked higher than
91% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. STJ: 18.11 )
Ranked among companies with meaningful Net-margin (%) only.
STJ' s 10-Year Net-margin (%) Range
Min: 2.17  Med: 13.74 Max: 17.87
Current: 18.11
2.17
17.87
ROE (%) 25.15
STJ's ROE (%) is ranked higher than
95% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. STJ: 25.15 )
Ranked among companies with meaningful ROE (%) only.
STJ' s 10-Year ROE (%) Range
Min: 3.02  Med: 17.55 Max: 23.77
Current: 25.15
3.02
23.77
ROA (%) 10.03
STJ's ROA (%) is ranked higher than
85% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: -0.33 vs. STJ: 10.03 )
Ranked among companies with meaningful ROA (%) only.
STJ' s 10-Year ROA (%) Range
Min: 1.65  Med: 9.75 Max: 15.43
Current: 10.03
1.65
15.43
ROC (Joel Greenblatt) (%) 42.54
STJ's ROC (Joel Greenblatt) (%) is ranked higher than
87% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 3.55 vs. STJ: 42.54 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
STJ' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 20.24  Med: 40.34 Max: 61.91
Current: 42.54
20.24
61.91
Revenue Growth (3Y)(%) 4.20
STJ's Revenue Growth (3Y)(%) is ranked higher than
56% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 3.00 vs. STJ: 4.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
STJ' s 10-Year Revenue Growth (3Y)(%) Range
Min: -6.7  Med: 11.20 Max: 21
Current: 4.2
-6.7
21
EBITDA Growth (3Y)(%) 6.10
STJ's EBITDA Growth (3Y)(%) is ranked higher than
56% of the 171 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. STJ: 6.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
STJ' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -4.6  Med: 14.50 Max: 22.2
Current: 6.1
-4.6
22.2
EPS Growth (3Y)(%) 11.00
STJ's EPS Growth (3Y)(%) is ranked higher than
65% of the 171 Companies
in the Global Medical Devices industry.

( Industry Median: -1.60 vs. STJ: 11.00 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
STJ' s 10-Year EPS Growth (3Y)(%) Range
Min: -37  Med: 13.10 Max: 120.5
Current: 11
-37
120.5
» STJ's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

STJ Guru Trades in Q3 2014

Ray Dalio 70,236 sh (New)
Joel Greenblatt 40,718 sh (+854.92%)
Paul Tudor Jones 24,056 sh (+216.82%)
Jim Simons 615,713 sh (+19.32%)
Jeremy Grantham 1,802,341 sh (+3.82%)
James Barrow 2,982,885 sh (+1.43%)
John Buckingham 111,888 sh (+0.89%)
John Rogers 1,227,309 sh (+0.57%)
Mario Gabelli 37,400 sh (unchged)
John Hussman 250,000 sh (unchged)
Bill Frels 2,090,259 sh (-0.35%)
David Dreman 31,333 sh (-1.27%)
Ken Fisher 255,663 sh (-1.82%)
Vanguard Health Care Fund 3,932,200 sh (-8.58%)
Steven Cohen 29,300 sh (-84.26%)
» More
Q4 2014

STJ Guru Trades in Q4 2014

Joel Greenblatt 137,476 sh (+237.63%)
Vanguard Health Care Fund 5,397,300 sh (+37.26%)
Jim Simons 744,713 sh (+20.95%)
Bill Frels 2,224,239 sh (+6.41%)
James Barrow 2,994,585 sh (+0.39%)
John Buckingham 112,006 sh (+0.11%)
Steven Cohen Sold Out
John Hussman Sold Out
John Rogers 1,219,961 sh (-0.60%)
David Dreman 30,297 sh (-3.31%)
Ken Fisher 243,188 sh (-4.88%)
Jeremy Grantham 1,695,176 sh (-5.95%)
Ray Dalio 64,136 sh (-8.69%)
Mario Gabelli 12,400 sh (-66.84%)
Paul Tudor Jones 3,452 sh (-85.65%)
» More
Q1 2015

STJ Guru Trades in Q1 2015

Louis Moore Bacon 300,000 sh (New)
Paul Tudor Jones 31,757 sh (+819.96%)
Joel Greenblatt 887,213 sh (+545.36%)
Vanguard Health Care Fund 6,023,679 sh (+11.61%)
John Rogers 1,280,608 sh (+4.97%)
James Barrow 3,030,643 sh (+1.20%)
Ken Fisher 244,337 sh (+0.47%)
Bill Frels 2,233,959 sh (+0.44%)
Mario Gabelli 12,400 sh (unchged)
Ray Dalio Sold Out
John Buckingham 111,193 sh (-0.73%)
David Dreman 28,952 sh (-4.44%)
Jeremy Grantham 1,514,727 sh (-10.64%)
Jim Simons 203,113 sh (-72.73%)
» More
Q2 2015

STJ Guru Trades in Q2 2015

Vanguard Health Care Fund 6,123,679 sh (+1.66%)
Ken Fisher 244,647 sh (+0.13%)
» More
» Details

Insider Trades

Latest Guru Trades with STJ

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 21.10
STJ's P/E(ttm) is ranked higher than
67% of the 156 Companies
in the Global Medical Devices industry.

( Industry Median: 29.20 vs. STJ: 21.10 )
Ranked among companies with meaningful P/E(ttm) only.
STJ' s 10-Year P/E(ttm) Range
Min: 12.71  Med: 23.60 Max: 51.32
Current: 21.1
12.71
51.32
Forward P/E 17.21
STJ's Forward P/E is ranked higher than
73% of the 96 Companies
in the Global Medical Devices industry.

( Industry Median: 23.31 vs. STJ: 17.21 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 21.10
STJ's PE(NRI) is ranked higher than
68% of the 154 Companies
in the Global Medical Devices industry.

( Industry Median: 29.20 vs. STJ: 21.10 )
Ranked among companies with meaningful PE(NRI) only.
STJ' s 10-Year PE(NRI) Range
Min: 12.69  Med: 23.59 Max: 51.47
Current: 21.1
12.69
51.47
P/B 5.40
STJ's P/B is ranked lower than
75% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 3.18 vs. STJ: 5.40 )
Ranked among companies with meaningful P/B only.
STJ' s 10-Year P/B Range
Min: 2.13  Med: 4.27 Max: 6.83
Current: 5.4
2.13
6.83
P/S 3.81
STJ's P/S is ranked lower than
59% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 3.11 vs. STJ: 3.81 )
Ranked among companies with meaningful P/S only.
STJ' s 10-Year P/S Range
Min: 1.84  Med: 3.30 Max: 7.01
Current: 3.81
1.84
7.01
PFCF 19.63
STJ's PFCF is ranked higher than
76% of the 115 Companies
in the Global Medical Devices industry.

( Industry Median: 31.27 vs. STJ: 19.63 )
Ranked among companies with meaningful PFCF only.
STJ' s 10-Year PFCF Range
Min: 9.89  Med: 21.77 Max: 41.61
Current: 19.63
9.89
41.61
POCF 16.85
STJ's POCF is ranked higher than
66% of the 149 Companies
in the Global Medical Devices industry.

( Industry Median: 22.43 vs. STJ: 16.85 )
Ranked among companies with meaningful POCF only.
STJ' s 10-Year POCF Range
Min: 7.91  Med: 15.19 Max: 28.47
Current: 16.85
7.91
28.47
EV-to-EBIT 20.14
STJ's EV-to-EBIT is ranked higher than
58% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 22.74 vs. STJ: 20.14 )
Ranked among companies with meaningful EV-to-EBIT only.
STJ' s 10-Year EV-to-EBIT Range
Min: 10  Med: 19.20 Max: 34.3
Current: 20.14
10
34.3
PEG 7.28
STJ's PEG is ranked lower than
75% of the 53 Companies
in the Global Medical Devices industry.

( Industry Median: 3.24 vs. STJ: 7.28 )
Ranked among companies with meaningful PEG only.
STJ' s 10-Year PEG Range
Min: 0.72  Med: 1.54 Max: 1121.5
Current: 7.28
0.72
1121.5
Shiller P/E 26.11
STJ's Shiller P/E is ranked higher than
63% of the 94 Companies
in the Global Medical Devices industry.

( Industry Median: 30.84 vs. STJ: 26.11 )
Ranked among companies with meaningful Shiller P/E only.
STJ' s 10-Year Shiller P/E Range
Min: 14.49  Med: 26.59 Max: 64.91
Current: 26.11
14.49
64.91
Current Ratio 1.15
STJ's Current Ratio is ranked lower than
88% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. STJ: 1.15 )
Ranked among companies with meaningful Current Ratio only.
STJ' s 10-Year Current Ratio Range
Min: 1.15  Med: 2.80 Max: 4.53
Current: 1.15
1.15
4.53
Quick Ratio 0.86
STJ's Quick Ratio is ranked lower than
83% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.02 vs. STJ: 0.86 )
Ranked among companies with meaningful Quick Ratio only.
STJ' s 10-Year Quick Ratio Range
Min: 0.86  Med: 1.92 Max: 3.54
Current: 0.86
0.86
3.54
Days Inventory 174.81
STJ's Days Inventory is ranked lower than
67% of the 280 Companies
in the Global Medical Devices industry.

( Industry Median: 130.93 vs. STJ: 174.81 )
Ranked among companies with meaningful Days Inventory only.
STJ' s 10-Year Days Inventory Range
Min: 146.43  Med: 168.60 Max: 297.37
Current: 174.81
146.43
297.37
Days Sales Outstanding 77.77
STJ's Days Sales Outstanding is ranked lower than
58% of the 274 Companies
in the Global Medical Devices industry.

( Industry Median: 68.45 vs. STJ: 77.77 )
Ranked among companies with meaningful Days Sales Outstanding only.
STJ' s 10-Year Days Sales Outstanding Range
Min: 70.8  Med: 93.02 Max: 101.34
Current: 77.77
70.8
101.34

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.52
STJ's Dividend Yield is ranked higher than
51% of the 180 Companies
in the Global Medical Devices industry.

( Industry Median: 1.44 vs. STJ: 1.52 )
Ranked among companies with meaningful Dividend Yield only.
STJ' s 10-Year Dividend Yield Range
Min: 0.39  Med: 1.68 Max: 2.81
Current: 1.52
0.39
2.81
Dividend Payout 0.31
STJ's Dividend Payout is ranked higher than
61% of the 110 Companies
in the Global Medical Devices industry.

( Industry Median: 0.40 vs. STJ: 0.31 )
Ranked among companies with meaningful Dividend Payout only.
STJ' s 10-Year Dividend Payout Range
Min: 0.28  Med: 0.32 Max: 0.63
Current: 0.31
0.28
0.63
Dividend growth (3y) 8.70
STJ's Dividend growth (3y) is ranked higher than
66% of the 47 Companies
in the Global Medical Devices industry.

( Industry Median: 3.30 vs. STJ: 8.70 )
Ranked among companies with meaningful Dividend growth (3y) only.
STJ' s 10-Year Dividend growth (3y) Range
Min: 0  Med: 0.00 Max: 8.7
Current: 8.7
0
8.7
Yield on cost (5-Year) 1.53
STJ's Yield on cost (5-Year) is ranked lower than
52% of the 180 Companies
in the Global Medical Devices industry.

( Industry Median: 1.60 vs. STJ: 1.53 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
STJ' s 10-Year Yield on cost (5-Year) Range
Min: 0.39  Med: 1.69 Max: 2.81
Current: 1.53
0.39
2.81
Share Buyback Rate 4.00
STJ's Share Buyback Rate is ranked higher than
96% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: -4.00 vs. STJ: 4.00 )
Ranked among companies with meaningful Share Buyback Rate only.
STJ' s 10-Year Share Buyback Rate Range
Min: 4.2  Med: 2.00 Max: -16.1
Current: 4

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.68
STJ's Price/Projected FCF is ranked higher than
62% of the 101 Companies
in the Global Medical Devices industry.

( Industry Median: 2.13 vs. STJ: 1.68 )
Ranked among companies with meaningful Price/Projected FCF only.
STJ' s 10-Year Price/Projected FCF Range
Min: 0.89  Med: 1.62 Max: 5.41
Current: 1.68
0.89
5.41
Price/DCF (Earnings Based) 1.24
STJ's Price/DCF (Earnings Based) is ranked higher than
69% of the 16 Companies
in the Global Medical Devices industry.

( Industry Median: 1.66 vs. STJ: 1.24 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.16
STJ's Price/Median PS Value is ranked lower than
53% of the 243 Companies
in the Global Medical Devices industry.

( Industry Median: 1.11 vs. STJ: 1.16 )
Ranked among companies with meaningful Price/Median PS Value only.
STJ' s 10-Year Price/Median PS Value Range
Min: 0.58  Med: 1.06 Max: 2.06
Current: 1.16
0.58
2.06
Earnings Yield (Greenblatt) (%) 5.00
STJ's Earnings Yield (Greenblatt) (%) is ranked higher than
79% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.80 vs. STJ: 5.00 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
STJ' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 2.9  Med: 5.20 Max: 10
Current: 5
2.9
10
Forward Rate of Return (Yacktman) (%) 5.12
STJ's Forward Rate of Return (Yacktman) (%) is ranked higher than
55% of the 100 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. STJ: 5.12 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
STJ' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 4.5  Med: 19.70 Max: 24.6
Current: 5.12
4.5
24.6

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, EW » details
Traded in other countries:JUD.Germany,
St Jude Medical Inc was incorporated in Minnesota in 1976. It develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The Company's two segments are the Implantable Electronic Systems Division and the Cardiovascular and Ablation Technologies Division. The Company's principal products in each business unit are as follows: Implantable Electronic Systems Division (IESD) - tachycardia implantable cardioverter defibrillator systems (ICDs), bradycardia pacemaker systems (pacemakers) and neurostimulation products (spinal cord and deep brain stimulation devices); and Cardiovascular and Ablation Technologies Division (CATD) - vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories), structural heart products (heart valve replacement and repair products and structural heart defect devices) and atrial fibrillation (AF) products (electrophysiology (EP) introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems). Implantable Electronic Systems Division (IESD): IESD is focused on the cardiac rhythm management and neuromodulation therapy areas. Cardiac rhythm management devices include ICDs that provide life-saving therapy to patients suffering from lethal heart conditions, such as sudden cardiac arrest; cardiac resynchronization therapy (CRT) devices to save and improve the lives of patients suffering from heart failure (HF); pacemakers to help patients whose hearts beat too slowly or who suffer from other debilitating cardiac arrhythmias; leads (wires that connect devices to the heart) to carry electrical impulses to the heart and provide information from the heart to the device; and programmers and remote monitoring equipment which are used by physicians and healthcare professionals to program is cardiac rhythm management devices and analyze device data to improve patient management. Neuromodulation product offerings provide neurostimulation treatment in which an implantable device delivers electrical current directly to targeted nerve sites. The Company's commercialized neurostimulation therapies include spinal cord stimulation (SCS) for the treatment of chronic pain, deep brain stimulation (DBS) for treating the symptoms of Parkinson's disease and peripheral nerve stimulation (PNS) for the treatment of chronic migraine headache. A neurostimulation system typically consists of four components: a pulse generator that produces the electrical current and is implanted under the patient's skin; implanted leads that carry the electrical impulses to the targeted nerve sites; an external patient remote control that enables the patient to control his or her therapy within prescribed ranges; and an extern
» More Articles for STJ

Headlines

Articles On GuruFocus.com
Weekly 52-Week Highs Highlight: GILD, XL, STJ, NKE Jun 20 2015 
Weekly Insider Sells Highlight: JNJ, TRV, AAL, STJ May 03 2015 
Reversing a Declining Pattern in Earnings Per Share Feb 24 2015 
Medtronic Q3 Earnings 2015 Exceeds Market Expectations Feb 19 2015 
Stocks Clocking Record Dividend Hike Feb 17 2015 
A Robust Q4 Earnings Report From Boston Scientific Feb 10 2015 
Boston Scientific Lost the First Place in Innovation Dec 11 2014 
John Rogers Ariel Appreciation Fund Q3 Commentary Oct 25 2014 
EW: Potential for Capital Appreciation Oct 03 2014 
No More a Simple Distributor Sep 07 2014 

More From Other Websites
THORATEC CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Jul 27 2015
Thoratec Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC... Jul 24 2015
St. Jude Medical downgraded by Deutsche Bank Jul 23 2015
St. Jude Medical (STJ) Stock Downgraded at Deutsche Bank, BMO Capital Jul 23 2015
Why You Should Hold Your Bets On the St. Jude Medical, Inc. (STJ) and Thoratec Corporation (THOR)... Jul 23 2015
Breakout Watch: Abiomed Pumps Up Before Q2 Earnings Jul 23 2015
BMO Capital Downgrades St. Jude Medical On 'Less Compelling' Risk/Reward Jul 23 2015
Morgan & Morgan Announces the Investigation of Thoratec Corp. - THOR Jul 22 2015
Harwood Feffer LLP Announces Investigation of Thoratec Corporation Jul 22 2015
St. Jude Medical, Inc. -- Moody's reviews St. Jude Medical's Baa1 rating for downgrade Jul 22 2015
Robbins Arroyo LLP: Acquisition of Thoratec Corp. (THOR) by St. Jude Medical, Inc. (STJ) May Not Be... Jul 22 2015
Edited Transcript of STJ earnings conference call or presentation 22-Jul-15 12:00pm GMT Jul 22 2015
St. Jude Medical (STJ) Stock Gains Following Earnings Beat Jul 22 2015
Thoratec (THOR) Stock Jumps After St. Jude Medical Takeover Offer Jul 22 2015
ST JUDE MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Jul 22 2015
Early movers: BA, KO, XOM, CPB, WHR, Z & more Jul 22 2015
St. Jude Medical and Thoratec Announce Definitive Agreement Jul 22 2015
Heart device maker St. Jude to buy Thoratec for $3.4 bln Jul 22 2015
St. Jude Medical and Thoratec Announce Definitive Agreement Jul 22 2015
Q2 2015 St. Jude Medical Inc Earnings Release - Before Market Open Jul 22 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK